A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants-Reference-Cited by-同舟云学术

A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants

Published:2010-04-15 Issue:4 Volume:6 Page:e1000745
ISSN:1553-7358
Container-title:PLoS Computational Biology
language:en
Short-container-title:PLoS Comput Biol

Author:

Adiwijaya Bambang S.,Herrmann Eva,Hare Brian,Kieffer Tara,Lin Chao,Kwong Ann D.,Garg Varun,Randle John C. R.,Sarrazin Christoph,Zeuzem Stefan,Caron Paul R.

Publisher

Public Library of Science (PLoS)

Subject

Computational Theory and Mathematics,Cellular and Molecular Neuroscience,Genetics,Molecular Biology,Ecology,Modeling and Simulation,Ecology, Evolution, Behavior and Systematics

Reference49 articles.

1. Hepatitis C virus: historical perspective and current concepts.;RH Purcell;FEMS Microbiol Rev,1994

2. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection.;MW Fried;New Engl J Med,2002

3. Future therapies for hepatitis C: where do we go from here?;S Sigal;Nat Clin Pract Gastr,2007

4. VX-950, a novel hepatitis c virus (hcv) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells.;K Lin;Antimicrob Agents Ch,2006

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracellular “In Silico Microscopes”—Comprehensive 3D Spatio-Temporal Virus Replication Model Simulations;Viruses;2024-05-24

2. Exploiting in silico modelling to enhance translation of liver cell therapies from bench to bedside;npj Regenerative Medicine;2024-05-09

3. CONTINUALLY HUMBLING, ENDLESSLY FASCINATING, AND UNFAILINGLY REWARDING: PRACTICAL LESSONS FROM A LIFELONG QUEST TO DISCOVER BREAKTHROUGH MEDICINES;2022 Medicinal Chemistry Reviews;2022-12-21

4. Mutational spectrum of hepatitis C virus in patients with chronic hepatitis C determined by single molecule real-time sequencing;Scientific Reports;2022-04-30

5. Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future;Clinical Pharmacology & Therapeutics;2021-03-09